AGP Executive Report
Last update: an hour agoUS-China Biopharma Clash: A judge temporarily blocked the Pentagon from labeling WuXi AppTec a “Chinese military company,” sending shares up as litigation plays out. Health Policy & Access: Liberia’s finance and health ministries held a “deep dive” to speed budget execution for health projects. Clinical Innovation: Reacta Healthcare named Iedena Lima head of R&D, while Oculis agreed to buy Accure’s Privosegtor rights to strengthen its neuro-ophthalmology pipeline. Rare Disease Moves: Sobi and Innate Pharma partnered to advance lacutamab toward TELLOMAK-3 Phase 3 confirmatory work in cutaneous T-cell lymphoma. Public Health Capacity: Kenya’s MMUST secured Sh11.7bn to build a mental health, community health and infectious diseases centre. Food Safety: Taylor Farms recalled select salsa and guacamole over possible salmonella contamination. Workforce & Training: U.Va. Health’s “Earn While You Learn” nursing track graduated its first cohort, expanding paid training pathways. Tech for Health: Nigeria’s malaria programme and Sproxil explored AI and private-sector data to accelerate surveillance and elimination efforts.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
